A detailed history of Wolverine Trading, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Wolverine Trading, LLC holds 11,652 shares of EXAS stock, worth $574,560. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,652
Previous 8,807 32.3%
Holding current value
$574,560
Previous $599,000 9.18%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$49.33 - $71.97 $140,343 - $204,754
2,845 Added 32.3%
11,652 $654,000
Q3 2024

Nov 14, 2024

SELL
$42.43 - $70.83 $141,461 - $236,147
-3,334 Reduced 27.46%
8,807 $599,000
Q2 2024

Aug 14, 2024

SELL
$41.33 - $74.26 $246,326 - $442,589
-5,960 Reduced 32.93%
12,141 $512,000
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $614,018 - $804,978
10,912 Added 151.79%
18,101 $1.25 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $424,582 - $544,351
7,189 New
7,189 $531,000
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $210,325 - $315,421
4,457 New
4,457 $295,000
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $392,152 - $544,578
-5,409 Reduced 19.77%
21,954 $1.71 Million
Q3 2021

Nov 12, 2021

BUY
$90.24 - $124.05 $561,112 - $771,342
6,218 Added 29.41%
27,363 $2.51 Million
Q2 2021

Aug 06, 2021

BUY
$93.66 - $139.27 $1.22 Million - $1.82 Million
13,048 Added 161.15%
21,145 $2.71 Million
Q1 2021

May 14, 2021

SELL
$116.57 - $155.01 $680,419 - $904,793
-5,837 Reduced 41.89%
8,097 $1 Million
Q4 2020

Feb 12, 2021

BUY
$99.61 - $142.12 $140,151 - $199,962
1,407 Added 11.23%
13,934 $1.89 Million
Q3 2020

Nov 13, 2020

SELL
$72.92 - $102.01 $93,483 - $130,776
-1,282 Reduced 9.28%
12,527 $1.28 Million
Q2 2020

Aug 13, 2020

SELL
$55.75 - $92.75 $1.06 Million - $1.76 Million
-18,984 Reduced 57.89%
13,809 $1.19 Million
Q1 2020

May 11, 2020

BUY
$37.9 - $104.44 $666,661 - $1.84 Million
17,590 Added 115.7%
32,793 $1.92 Million
Q4 2019

Feb 12, 2020

BUY
$77.66 - $99.74 $978,826 - $1.26 Million
12,604 Added 484.96%
15,203 $1.4 Million
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $351,991 - $477,098
-3,895 Reduced 59.98%
2,599 $239,000
Q2 2019

Aug 20, 2019

SELL
$89.51 - $118.04 $1.21 Million - $1.59 Million
-13,506 Reduced 67.53%
6,494 $767,000
Q1 2019

May 15, 2019

SELL
$61.98 - $96.5 $364,070 - $566,841
-5,874 Reduced 22.7%
20,000 $1.73 Million
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $470,063 - $693,352
-8,388 Reduced 24.48%
25,874 $1.58 Million
Q3 2018

Nov 14, 2018

BUY
$48.29 - $80.6 $369,659 - $616,993
7,655 Added 28.77%
34,262 $2.7 Million
Q1 2018

May 15, 2018

SELL
$39.82 - $57.53 $1.1 Million - $1.59 Million
-27,684 Reduced 50.99%
26,607 $1.07 Million
Q4 2017

Feb 14, 2018

BUY
$46.49 - $60.51 $44,955 - $58,513
967 Added 1.81%
54,291 $2.85 Million
Q3 2017

Nov 15, 2017

BUY
$37.05 - $47.12 $1.98 Million - $2.51 Million
53,324
53,324 $2.51 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.73B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.